BioCryst (BCRX) Soars 13% on Acquisition Buzz
BioCryst snapped a three-day losing streak on Monday, jumping 13.14 percent to finish at $9.30 apiece, as investors loaded portfolios amid rumors that it is set to be acquired by a large-cap biopharmaceutical...







